Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of...

23
1-P1-LB46 Clustering of acetylcholine receptors in a muscular atrophy model Yuko Fukunaga , Yo Kimura, Hina Kikuchi, Haruka Furuyama Animal Risk Management, Chiba Institute of Science LBS Copyright © The Japanese Pharmacological Society

Transcript of Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of...

Page 1: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

1-P1-LB46

Clustering of acetylcholine receptors in a muscular atrophy model

Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama

Animal Risk Management, Chiba Institute of Science

LBS

Copyright © The Japanese Pharmacological Society

Page 2: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

1-P1-LB47

Differential projection patterns between the insular and medial prefrontalcortices to the the nucleus accumbens in rats

Yuka Nakaya, Kiyofumi Yamamoto, Masayuki Kobayashi

Department of Pharmacology, Nihon University School of Dentistry

LBS

Copyright © The Japanese Pharmacological Society

Page 3: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

1-P1-LB48

Presynaptic NK1 receptor activation by substance P suppresses EPSCs vianitric oxide synthesis in the rat insular cortex

Matsumura Sachie, Kiyofumi Yamamoto, Masayuki Kobayashi

Dept. Pharmacol., Nihon Univ. Sch. of Dent.

LBS

Copyright © The Japanese Pharmacological Society

Page 4: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

1-P1-LB49

Assessment of CB agonist CP55940 in maturity for rat hippocampal neuronsusing a high-throughput immunocytochemical assay and image digitalanalysis

Mitsuoka Toshinari1, Shogo Mase1,2, Noriko Koganezawa2, Yuichi Katou1, Izuo Tutui1,Tomoaki Shirao2, Yuko Sekino1

1Lab. HCBDD, Grad. Sch. Pharm, Univ Tokyo, 2Dept Pharmacol, Gunma Univ, Grad Sch Med.

LBS

Copyright © The Japanese Pharmacological Society

Page 5: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

1-P1-LB50

Deficit of cognitive function induced by the reduction of mice hippocampalShati/Nat8l

Ikejima Daiki1, Shin-ichi Muramatsu2,3, Atsumi Nitta1

1Grad. Sch.Med. Pharm Sci., Toyama Univ,2Jichi Medical Univ, 3Tokyo Univ

LBS

Copyright © The Japanese Pharmacological Society

Page 6: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

1-P2-LB47

Enhancement of myogenic differentiation by MMP inhibition and attenuationof the enhancement effect in senescent cells

Hiroki Sakai1, Takeshi Honda1, Kouetsu Ogasawara2, Masataka Asagiri1

1Yamaguchi Univ. Grad. Sch. Med.,2IDAC. Tohoku Univ.

LBS

Copyright © The Japanese Pharmacological Society

Page 7: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

1-P2-LB48

Changes in expression of fibrosis-related factors in alveolar epithelial cellsand macrophages by forced expression of p16

Yasuhiro Takenouchi, Yoshifumi Niiyama, Keisuke Kitakaze, Kazuhito Tsuboi, Yasuo Okamoto

Dept. Pharmacol., Kawasaki Med. Sch.

LBS

Copyright © The Japanese Pharmacological Society

Page 8: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

1-P2-LB49

Signal transduction mechanism for S-allyl-L-cysteine-induced cellproliferation in primary cultures of adult rat hepatocytes

Hajime Moteki, Kazuki Kurihara, Masahiko Ogihara, Mitshtoshi Kimura

Dept. Clin. Pharmacol., Fac. Pharma. Sci., Josai Univ.

LBS

Copyright © The Japanese Pharmacological Society

Page 9: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

1-P2-LB50

The oxidative stress response and signaling pathways in diffuse- andintestinal-type gastric cancer.

Shihori Tanabe1, Sabina Quader2, Ryuichi Ono3, Horacio Cabral4, Kazuhiko Aoyagi5,Akihiko Hirose1, Ed Perkins6, Hiroshi Yokozaki7, Hiroki Sasaki8

1Div. Risk Assess., CBSR, Natl. Inst. Health Sci., 2iCONM, 3Div. Cell. Mol. Tox., CBSR, Natl. Inst. Health Sci.,4Grad. Sch. Engineer., The Univ. of Tokyo,5Dept. Clin. Genomics, FIOC, Natl. Cancer Ctr. Res. Inst., 6USACEERDC Environ. Lab., 7Dept. Path. Grad. Sch. Med., Kobe Univ., 8Dept. Transl. Oncol., FIOC, Natl. Cancer Ctr.Res. Inst.

LBS

Copyright © The Japanese Pharmacological Society

Page 10: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

2-P1-LB45

Physiological function of the descending projection from the insular cortexto the parabrachial nucleus revealed by optogenetics

Kensuke Hirose, Yuka Nakaya, Masayuki Kobayashi

Dept. of Pharmacol. Nihon Univ. Sch. of Dent.

LBS

Copyright © The Japanese Pharmacological Society

Page 11: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

2-P1-LB46

Restoration of CLSP activity rescues Alzheimer disease

Masaaki Matsuoka, Yuichi Hashimoto, Shinya Kusakari, Mikiro Nawa, Yuka Toyama

Department of Pharmacology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan

LBS

Copyright © The Japanese Pharmacological Society

Page 12: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

2-P1-LB47

The Nrf2 gene may not be involved in the anti-inflammatory effects of Nrf2activators

Yasuhiko Izumi1, Momoko Uegomori1, Fumika Kobayashi1, Koya Koya Yamaki1, Toshiaki Kume2,Yutaka Koyama1

1Lab. Pharmacol., Kobe Pharm. Univ., 2Dept. Appl. Pharmacol, Grad. Sch. of Med. and Pharm. Sci., Univ. ofToyama

LBS

Copyright © The Japanese Pharmacological Society

Page 13: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

2-P1-LB48

Influence of mitochondria dysfunction in microglia on inflammation-evokedtype I interferon expression

Momoka Iwamoto, Yoki Nakamura, Kazue Nakashima, Norimitsu Morioka

Dept. Pharmacol., Grad.Sch. Biomed. & Helth Sci., Hiroshima Univ.

LBS

Copyright © The Japanese Pharmacological Society

Page 14: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

2-P1-LB49

The effects of chronic administration of methamphetamine on circadianrhythm of mice

Nakaya Mizuki, Ryousuke Sato, Kouki Nagasawa, Yukina Yoshida, Juri Hayashi, Yuki Ishi,Kazuko Hamada, Toshiyuki Hamada

IUHW

LBS

Copyright © The Japanese Pharmacological Society

Page 15: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

2-P2-LB47

Involvement of TRPC3-Nox2 axis in Duchenne muscular dystrophy

Koichi Ayukawa1, Chiemi Toyama1, Kazuhiro Nishiyama1, Yuri Kato1, Tomohiro Tanaka2,Akiyuki Nishimura2, Motohiro Nishida1,2

1Graduate School of Pharmaceutical Sciences, Kyushu University, 2National Institute for Physiological Sciencesand Exploratory Research Center on Life and Living Systems, National Institutes of Natural Sciences

LBS

Copyright © The Japanese Pharmacological Society

Page 16: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

2-P2-LB48

Suppression of SARS-CoV-2-induced lung injury by ACE2-likecarboxypeptidase B38-CAP in COVID-19 mouse model

Tomokazu Yamaguchi1, Takafumi Minato1, Midori Hoshizaki1,2, Masamitsu Asaka3,Satoru Nirasawa4, Mayumi Niiyama5, Masaki Imai6, Saori Takahashi7, Daichi Utsumi3,Jianbo An1, Satoshi Nagata5, Haruhiko Kamada5, Yoshihiro Kawaoka6, Yasuhiro Yasutomi3,Yumiko Imai2, Keiji Kuba1

1Department of Biochemistry and Metabolic Science, Akita University, 2Laboratory of Regulation of IntractableInfectious Diseases, NIBIOHN, 3Tsukuba Primate Research Center, NIBIOHN,4Biological Resources and Post-Harvest Division, Japan International Research Center for Agricultural Sciences, 5Laboratory of Antibody Design,NIBIOHN, 6Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science,University of Tokyo, 7Akita Research Institute of Food and Brewing

LBS

Copyright © The Japanese Pharmacological Society

Page 17: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

2-P2-LB49

Novel role of pyruvate dehydrogenase PDH regulation of histoneacetylation and gene expression in breast cancer cells

Nakayama Koh

Dept. of Pharmacol., Asahikawa Med. Univ.

LBS

Copyright © The Japanese Pharmacological Society

Page 18: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

2-P2-LB50

Mitochondrial fusion factor OPA1 sustains gefitinib-resistance in lungadenocarcinoma cells

Masafumi Noguchi1, Susumu Kohno2, Keitaro Shibata1, Takashi Kohno3, Noriko Gotoh4,Chiaki Takahashi4, Atsushi Hirao5, Luca Scorrano1, Atsuko Kasahara4

1Dept. of Biol., Univ. of Padua, Venetian Inst. of Mol. Med.,2Cancer Res. Inst., Kanazawa Univ., 3National CancerCtr. Res. Inst., 4Inst. for Frontier Sci. Initiative, Cancer Res. Inst., Kanazawa Univ., 5Cancer Res. Inst., WPI NanoLife Sci. Inst., Kanazawa Uni.

LBS

Copyright © The Japanese Pharmacological Society

Page 19: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

3-P1-LB46

Electrophysiological and anatomical properties of neurons in theventrolateral part of the periaqueductal gray matter in the rat

Kawasaki Shiori, Yuka Nakaya, Masayuki Kobayashi

Dept. Pharmacol., Nihon Univ Sch Dent.

LBS

Copyright © The Japanese Pharmacological Society

Page 20: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

3-P1-LB47

Influences of prenatal stress by the communication box on GABAergicsystem in the amygdala of mice.

Takayoshi Mamiya1, Ping Lu1, Lingling Lu1, Hiroshi Oda1, Akihiro Mouri1,2,Toshitaka Nabeshima1,2, Masayuki Hiramatsu1

1Dept. Chem. Pharmacol., Fac. Pharm., Meijo Univ., 2Adv. Diagn Sys. Res. Lab., Grad. Sch. Health Sci., FujitaHealth Univ.

LBS

Copyright © The Japanese Pharmacological Society

Page 21: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

3-P2-LB48

Relationship between plasma extracellular vesicles (EV) and systemic bloodpressure in Otsuka Long-Evans Tokushima Fatty (OLETF) rats

Risa Teranishi, Kosuke Otani, Muneyoshi Okada, Hideyuki Yamawaki

Lab. Vet Pharmacol., Sch. Vet. Med., Kitasato Univ.

LBS

Copyright © The Japanese Pharmacological Society

Page 22: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

3-P2-LB49

Reduced white adipose tissue amount in mice lacking mitochondrial proteinp13

Hara Satomi1, Hiroki Ueno1, Masafumi Noguchi2, Wakana Matsuo1, Hitoshi Hashimoto1,3,4,5,6,Norihito Shintani1

1Lab. Mol. Neuropharmacol., Grad. Sch. Pharmaceut. Sci., Osaka Univ., 2Dept. Biol., Univ. Padova, 3United Grad.Sch. Child Dev., Osaka Univ., 4Div. Biosci., Inst. Datability Sci., Osaka Univ., 5Transdimensional Life Imaging Div.,Inst. Open Transdiscip. Res. Initiatives, Osaka Univ, 6Dept. Mol. Pharmaceut. Sci., Grad. Sch. Med., Osaka Univ.

LBS

Copyright © The Japanese Pharmacological Society

Page 23: Yuko Fukunaga, Yo Kimura, Hina Kikuchi, Haruka Furuyama · 2021. 3. 6. · 2-P2-LB48 Suppression of SARS-CoV-2-induced lung injury by ACE2-like carboxypeptidase B38-CAP in COVID-19

3-P2-LB50

Novel Reporter Systems Monitoring NFkB activation Can Be Applied toHigh-Throughput Screening.

Yonezawa Tomo

LBS

Copyright © The Japanese Pharmacological Society